Clinical Trial Update: The Sub-Sero Study [Phase 2]

View source ↗

Summary

Phase 2 trial titled 'The Sub-Sero Study' sponsored by Bjorn H. Ebdrup has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Snippet

Sponsor: Bjorn H. Ebdrup | Conditions: Schizophrenia, Psychosis | Phase 2 | Status: WITHDRAWN